US Patent 9061043 Aptamers to glycoprotein VI
Patent 9061043 was granted and assigned to Duke University on June, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+532 characters)
Article
Patent abstract
The present invention relates, in general, to glycoprotein VI (GPVI) and, in particular, to aptamers to GPVI and to compositions comprising same. The invention also relates to methods of inhibiting platelet aggregation using an aptamer that binds to and inhibits the activity of GPVI. The invention further relates to antidotes to GPVI aptamers and to methods of using such antidotes to reverse aptamer-induced platelet inhibition. The invention also relates to aptamers that bind to and enhance the activity of GPVI.
Edits on 28 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Bruce A. Sullenger0
Kristin M. Bompiani0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09061043 Aptamers to glycoprotein VI US Patent 9061043 Aptamers to glycoprotein VI
Infobox
Patent Number
09061043
Patent Number
9061043
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09061043 Aptamers to glycoprotein VI
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09061043
Date of patent
June 23, 2015
Patent application number
13878539
Date Filed
October 13, 2011
Patent primary examiner
Find more entities like US Patent 9061043 Aptamers to glycoprotein VI
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.